GlassScriptPhysician profile
Gwen D Abeles
NPI 1447222625
$9,297.80
in general payments reported to CMS, 2019-2025
42 companies · $2,841 in 2025
The $2,841 reported for 2025 was more than what 83% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $304 · 2021: $141 · 2022: $604 · 2023: $1,859 · 2024: $1,894 · 2025: $2,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,488 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,487.95 |
| Education | $106.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,567.87 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $671.92 | 2019-2025 | Odomzo, Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $653.30 | 2020-2025 | Dupixent, Libtayo |
| Biofrontera INC. | $551.60 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $510.13 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $467.15 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $416.84 | 2022-2025 | Olumiant, Taltz |
| Janssen Biotech, INC. | $405.97 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Incyte Corporation | $375.88 | 2022-2024 | Opzelura |
| Galderma Laboratories, L.P. | $375.39 | 2019-2025 | Aklief, Nemluvio |
| Pfizer INC. | $348.74 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $336.33 | 2019-2025 | Cabtreo, Jublia, Arazlo |
| Leo Pharma INC. | $275.60 | 2019-2025 | Adbry, Anzupgo |
| Verrica Pharmaceuticals INC. | $207.41 | 2023-2024 | Ycanth |
| Abbvie INC. | $188.15 | 2019-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gwen Abeles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.